Understanding the Role of Brain Immune Cells in Protection Against Alzheimer’s

Principal Investigator
Ghazaleh Eskandari-Sedighi, PhD
University of California, Irvine
Irvine, CA, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$200,000
Active Dates
July 01, 2025 - June 30, 2027
Grant ID
A2025007F
Goals
Our goal is to learn about naturally available ways the brain fights against Alzheimer’s disease to help the development of more efficient therapeutics.
Summary
Understanding how Alzheimer’s disease (AD) is formed is challenging due to the complex, multifaceted nature of the disease. It is known now that the heritability of AD is over 60%. So, understanding the disease mechanism can be achieved by exploring these hereditary elements in patients vs. healthy individuals. Of note, some rare hereditary factors turn out to be protective and can provide protection against AD. Taking advantage of novel, multi-faceted stem cell models, we will study ApoE3 Christchurch as one of these rare, resilient factors, with a specific focus on brain-resident immune cells.
Unique and Innovative
Taking advantage of human stem cell techniques, we use a novel state-of-the-art model that enables studying biology of human brain resident immune cells. Moreover, we have recently made advancements in enhancing our model to better recapitulate all aspects of Alzheimer’s disease. This research may help explain why some people with high levels of Alzheimer’s disease toxic proteins stay healthier than others.
Foreseeable Benefits
Our proposed experiments will help reveal mechanisms of protective paths that the brain immune cells take. This information will provide valuable new insight that could inform the development of promising new therapeutic approaches.
Related Grants
Alzheimer's Disease Research
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027
Principal Investigator
Frances Wiseman, PhD
Current Organization
University College London (UK)
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027

Principal Investigator
Frances Wiseman, PhD
Current Organization
University College London (UK)
Alzheimer's Disease Research
The Astrocyte Cell Surface Proteome in Alzheimer’s Disease
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Omar Peña-Ramos, PhD
Current Organization
Baylor College of Medicine
The Astrocyte Cell Surface Proteome in Alzheimer’s Disease
Active Dates
July 01, 2025 - June 30, 2027

Principal Investigator
Omar Peña-Ramos, PhD
Current Organization
Baylor College of Medicine
Alzheimer's Disease Research
Targeting the Adaptive Immunity to Prevent Alzheimer's Brain Degeneration
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Joshua Emmerson, PhD
Current Organization
Washington University in St.Louis
Targeting the Adaptive Immunity to Prevent Alzheimer's Brain Degeneration
Active Dates
July 01, 2025 - June 30, 2027

Principal Investigator
Joshua Emmerson, PhD
Current Organization
Washington University in St.Louis